manilatimes9m
Diag-Nose.io Expands to Bethlehem, PA, Following Oversubscribed $2M Seed Round Funding to Revolutionize Respiratory Diagnostics
A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...
Invenra and Orion Announce Discovery Service and Commercial License Agreement to Develop Innovative Bispecific Antibody Cancer Therapeutics
Orion Corporation ("Orion"), a globally operating pharmaceutical company, and Invenra Inc., an innovative biotechnology company with proprietary technologies for discovering novel therapeutics, today ...
Borrowing nature's blueprint: Scientists replicate bone marrow
Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to ...
Cosmetics Business11h
L'Oréal-backed biotech firm Debut launches AI ingredient discovery platform
L'Oréal -backed biotech firm Debut has released an artificial intelligence (AI)-powered ingredient discovery platform aimed at the beauty industry. BeautyORB works to discover novel ingredients and ...
ThePrint11h
CBI files closure report in UGC-NET case, juvenile who ‘doctored’ paper let off after counselling
CBI filed the report after confirming there was no paper leak. A school student doctored a screenshot & earned Rs 20,000 by ...
labiotech12h
Seven genomics startups to look out for
Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...
Nurix Therapeutics' SWOT analysis: protein degrader stock's potential
Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...
BioNTech's SWOT analysis: oncology pipeline, cash boost stock outlook
BioNTech SE (NASDAQ:BNTX), a biotechnology company renowned for its mRNA technology platform and COVID-19 vaccine success, is navigating a crucial phase in its evolution. With a market capitalization ...